145 related articles for article (PubMed ID: 34811879)
1. Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemia.
Rosenfeld E; Getz KD; Miller TP; Seif AE; Fisher BT; Burrows E; Ramos MJ; De León DD; Aplenc R; Morales KH; Guevara JP
Pediatr Blood Cancer; 2022 Jun; 69(6):e29467. PubMed ID: 34811879
[TBL] [Abstract][Full Text] [Related]
2. Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens.
Denton CC; Rawlins YA; Oberley MJ; Bhojwani D; Orgel E
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29218844
[TBL] [Abstract][Full Text] [Related]
3. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia.
Halonen P; Salo MK; Mäkipernaa A
J Pediatr; 2001 Mar; 138(3):428-31. PubMed ID: 11241057
[TBL] [Abstract][Full Text] [Related]
4. Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG-ALL-2015.
Zhu Y; Yang R; Cai J; Yu J; Tang Y; Chen Y; Wang N; He H; Wu X; Cheng FWT; Sun L; He Y; Ju X; Tian X; Hu Q; Jin R; Pan K; Fang Y; Zhai X; Jiang H; Li CK
Cancer Med; 2020 Mar; 9(6):2113-2121. PubMed ID: 31994344
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemia and glycemic variability among children with acute lymphoblastic leukemia during maintenance therapy.
Trelinska J; Fendler W; Szadkowska A; Czerwoniuk D; Mianowska B; Wegner O; Mlynarski W
Leuk Lymphoma; 2011 Sep; 52(9):1704-10. PubMed ID: 21585281
[TBL] [Abstract][Full Text] [Related]
6. Cryptosporidiosis in children with acute lymphoblastic leukemia on maintenance chemotherapy.
Domenech C; Rabodonirina M; Bleyzac N; Pagès MP; Bertrand Y
J Pediatr Hematol Oncol; 2011 Oct; 33(7):570-2. PubMed ID: 21941152
[TBL] [Abstract][Full Text] [Related]
7. Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
Barone T; Dandekar S; McKeone D; Mulieri K
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1987. PubMed ID: 38351548
[TBL] [Abstract][Full Text] [Related]
8. The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
Melachuri S; Gandrud L; Bostrom B
Pediatr Blood Cancer; 2014 Jun; 61(6):1003-6. PubMed ID: 24415675
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
[TBL] [Abstract][Full Text] [Related]
10. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy.
Meenan CK; Kelly JA; Wang L; Ritchey AK; Maurer SH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27515. PubMed ID: 30362242
[TBL] [Abstract][Full Text] [Related]
11. Hepatotoxicity During Maintenance Therapy and Prognosis in Children With Acute Lymphoblastic Leukemia.
Ebbesen MS; Nygaard U; Rosthøj S; Sørensen D; Nersting J; Vettenranta K; Wesenberg F; Kristinsson J; Harila-Saari A; Schmiegelow K
J Pediatr Hematol Oncol; 2017 Apr; 39(3):161-166. PubMed ID: 28060115
[TBL] [Abstract][Full Text] [Related]
12. Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia.
Wu S; Wang M; Alqahtani A; Lou M; Stock W; Bhojwani D; Alachkar H
Biomed Pharmacother; 2022 Jun; 150():113000. PubMed ID: 35658244
[TBL] [Abstract][Full Text] [Related]
13. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Mullins J; Ferry RJ; DeAngulo G; Thomas PJ; Estrada J; Pitney A; Pollock BH
Pediatr Blood Cancer; 2005 Dec; 45(7):960-3. PubMed ID: 15700246
[TBL] [Abstract][Full Text] [Related]
14. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA
Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245
[TBL] [Abstract][Full Text] [Related]
16. Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report.
McNerney KO; Vasquez JC; Kent MW; McNamara JM
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e454-e455. PubMed ID: 28085749
[TBL] [Abstract][Full Text] [Related]
17. Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.
Schulte R; Hinson A; Huynh V; Breese EH; Pierro J; Rotz S; Mixon BA; McNeer JL; Burke MJ; Orgel E
Cancer Med; 2021 Nov; 10(21):7551-7560. PubMed ID: 34528411
[TBL] [Abstract][Full Text] [Related]
18. Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis.
Wu YP; Stenehjem DD; Linder LA; Yu B; Parsons BG; Mooney R; Fluchel MN
J Pediatr Oncol Nurs; 2018; 35(2):86-93. PubMed ID: 29188741
[TBL] [Abstract][Full Text] [Related]
19. Continuous glucose monitoring: a valuable monitoring tool for management of hypoglycemia during chemotherapy for acute lymphoblastic leukemia.
Visavachaipan N; Aledo A; Franklin BH; Brar PC
Diabetes Technol Ther; 2013 Jan; 15(1):97-100. PubMed ID: 23145966
[TBL] [Abstract][Full Text] [Related]
20. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
